Searched for
PHARMA MNCS
Diversity hiring jumps 21% despite slowdown in white-collar recruitment: founditWhite-collar hiring in India saw a slowdown in May 2026. However, diversity hiring experienced a substantial surge. This trend highlights a...- “Reallocate, Diversify, Reposition”: Ajay Srivastava flags rising macro risks for investorsIndian markets face rising macro risks from global shocks, currency pressure, and energy prices, impacting domestic consumption and corpora...
- When the world's an oyster for Sun (Pharma)Indian companies are increasingly making bold acquisitions abroad. Sun Pharma's deal signals a new era of deliberate empire-building. This ...
- Demand for senior technology leaders in India is bucking a slowdown in broader tech hiringAs per experts, many MNCs are considering shifting global tech positions to India, mostly to their GCCs. Ratna Gupta, senior partner, ABC C...
- Pharma MNCs seek relief from price control for patented drugsThe Organisation of Pharmaceutical Producers of India (OPPI) is requesting exemptions for patented and orphan drugs from government price c...
- Drug launches, new permissions should be made public, say pharma MNCsIn a recent meeting held by the drug controller on global clinical trials, the OPPI sought from the government a notification system throug...
- Why MNC pharma companies are realigning their India operationsAt a time when the local market is assuming the centre stage of the growth strategy for Indian pharma companies, multinational drugmakers a...
- Amit Rajan on why pharma MNCs are beating Indian counterpartsPatent protection, ban on fixed dose combinations among factors helping pharma MNCs
- Panel for blanket ban on FDI in brown field pharma unitsThe committee demands caution on the issue from the government and reiterates its recommendation to impose a blanket ban in FDI in brown fi...
- Pick-up in local market boosts pharma MNCsA pick-up in the local pharma market augurs well for MNCs which are still recovering from the adverse impact of drug price control on high-...
- Top three pharma MNCs Novartis, Pfizer and Abbott lose 10% in 2013Most MNCs have been facing heat due to fast expiring patents, challenges in new drug discovery and depleting product pipeline.
- Pharma MNCs current spend on R&D in India not significantThe low spend is indicative that the companies do not invest significantly in innovative R&D, with most of it being done outside India.
- Pharma MNCs run into rough weatherThe rejection of the Glivec patent has added to pharma MNCs’ woes after a slew of measures in the past one year.
- Pharma MNCs increase focus in Indian market: ICRAMulti-national pharma companies have increased their focus in the country following their rapid growth in the Indian market.
- Pharma MNCs GSK, Merck, Pfizer and others prefer tie-ups over acquisitions with Indian firmsWith Indian drug makers flooding the developed markets, GSK, Merck, Pfizer now prefer tie-ups over acquisitions with Indian players.
- Pharma MNCs eye Indian companies to collaborate on drugs, moleculesTo take advantage of the robust growth of the domestic pharma industry, MNCs are looking at alliances and partnerships.
- Small drug firms to seek protectionConcerned about the recent spate of takeovers of domestic pharma firms by MNCs, small and medium players in the sector have decided to appr...
- Pharma MNCs will call the shots soonForeign drugmakers are poised to regain the supremacy they ceded during the 1970s, thanks to their strategy of gobbling up India’s leading ...
- Pharma cos to disclose gifts to doctorsGSK to publish info on website, other MNC subsidiaries may follow suit.
- MNCs eye Indian pharmaAcquisitions of Indian pharma companies by large multinationals has raised fears.
Load More
